Lincoln Pharmaceuticals Ltd Share Price

Pharmaceuticals - Indian - Formulations

NSE: LINCOLN Small Cap ISIN: INE405C01035

As on 22 January 2025 at 18:32 IST

₹751.15

-19.05

(-2.47%)

Sell Buy

Over 1 Month

-4%

Over 6 Months

23.81%

Over 1 Year

16.34%

Over 3 Years

113.12%

Lincoln Pharmaceuticals Ltd Summary

Close ₹ 751.15

Open ₹ 770.20

High ₹ 774.45

Low ₹ 731.80

Volume 39,354

Net Turnover (in ₹) ₹ 3,43,23,356.95

52Wk High ₹ 979.50

52Wk Low ₹ 534.80

52Wk High / Low

534.80

979.50

Lincoln Pharmaceuticals Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 1,542.69

EPS (TTM) 48.25

Book Value (BV) 319.16

Div. Yield 0.23 %

P/E (TTM) 15.99

Price/Book Value 2.42

Delivery % 58.39 %

Face Value 10

Key Ratios

PE Ratio 12.57

PB Ratio 1.98

EV to Sales 2

PEG Ratio 0.45

ROA 15.61

ROE 17.04

Debt-Equity -

Net Profit Margin 16.07

Operating Profit Margin 23.14

Lincoln Pharmaceuticals Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	614.97	532.78	482.12	429.85	397.53
Total Expenses	492.73	432.30	386.18	346.13	330.30
Profit Before Tax	122.24	100.48	95.94	83.72	67.23
Profit After Tax	93.30	72.90	69.36	62.25	51.47
Operating Profit after Depreciation	123.71	102.51	97.39	85.28	69.25

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	179.33	150.53	131.88	110.64	122.72
Total Non Current Assets	253.55	220.21	181.51	143.61	141.39
Total Current Assets	446.74	367.21	352.85	308.75	248
TOTAL ASSETS	700.29	587.42	534.36	452.36	389.39
Total Shareholder's Fund	592.84	502.47	432.88	366.39	313.09

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	63.22	39.26	76.13	69.27	75.42
Net Cash used in Investing Activities	-57.34	-36.64	-78.08	-64.23	-30.88
Net Cash used in Financing Activities	-5.18	-4.50	-2.56	-5.75	-37.76

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	614.97	532.79	482.08	428.65	388.22
Total Expenses	492.73	432.34	386.15	344.98	324.17
Profit Before Tax	122.24	100.46	95.93	83.67	64.05
Profit After Tax	93.30	72.90	69.35	62.25	49.56
Operating Profit after Depreciation	123.71	102.48	97.38	85.22	66.03

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	179.33	150.53	131.88	110.64	91.03
Total Non Current Assets	253.60	220.26	181.56	143.66	151.83
Total Current Assets	446.55	367	352.56	308.15	215.38
TOTAL ASSETS	700.15	587.26	534.11	451.81	367.21
Total Shareholder's Fund	592.84	502.47	432.88	366.39	304.49

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	63.24	39.16	76.18	69.39	70.71
Net Cash used in Investing Activities	-57.34	-36.64	-78.08	-64.39	-28.99
Net Cash used in Financing Activities	-5.18	-4.50	-2.56	-5.74	-38.10

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	161.21	147.28	142.49	146.45	155.99
Total Expenses	132.84	124.55	124.11	116.79	124.84
Profit Before Tax	34.78	29.48	22.21	37.72	36.87
Profit After Tax	26.33	23.67	18.60	28.04	27.65
Operating Profit after Depreciation	38.35	33.14	25.40	40.68	39.84

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	161.21	147.28	142.49	146.45	155.99
Total Expenses	132.84	124.55	124.11	116.79	124.84
Profit Before Tax	34.78	29.48	22.21	37.72	36.87
Profit After Tax	26.33	23.67	18.60	28.04	27.65
Operating Profit after Depreciation	38.35	33.14	25.40	40.68	39.84

Lincoln Pharmaceuticals Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 754.27

S2 738.33

S3 711.67

Pivot 780.93

R1 796.87

R2 823.53

R3 839.47

Moving Average

20 SMA 803.45

50 SMA 777.78

100 SMA 738.31

200 SMA 679.30

Lincoln Pharmaceuticals Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

Lincoln Pharmaceuticals Ltd

₹1.8/Share

Announcement Date 13 Sep 2024

Record Date 14 Sep 2024

Div Yield 18%

AGM Date: 30 Sep 2022

AGM 30/09/2022 Proceeding of the 28th Annual General Meeting of The Company-Regulation 30 of SEBI (LODR) Regulation,2015 (As Per BSE Announcement dated on 30.09.2022) Minutes of the 28th Annual General Meeting (As Per BSE Announcement Dated on 14.10.2022)

AGM Date: 30 Sep 2023

Intimation of Publication of Notice. Pursuant to the regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the 29th Annual General Meeting of the Company is scheduled to be held on Saturday, September 30, 2023 at 11:00 a.m. (IST) through video conferencing ('VC')/Other Audio-Visuals Means ('OAVM'). (As Per BSE Announcement Dated on 28/08/2023) Proceedings of the 29th Annual General Meeting of the Company held today. (As per BSE Announcement Dated on 30/09/2023) With reference to the above, please find enclosed herewith the minutes of 29th Annual General Meeting of the Company held at 11:00 A.M on Saturday, the 30th September , 2023 through Video Conferencing ('VC')/other Audio Visual Means (OVAM) to seek the approval of members of the company on resolutions set out in the Notice convening the meeting. (As Per BSE Announcement Dated on 23.10.2023)

AGM Date: 30 Sep 2024

AGM 30/09/2024 Submission of proceedings of the 30th Annual General Meeting of the Company held today. (As Per Bse Announcement Dated on 30.09.2024) Submission of Voting Results of 30th AGM along with the Scrutinizer Report as per Regulation 44 of SEBI (LODR) Regulation, 2015. Submission of Scrutinizers'' Report of 30th AGM of the Company. (As per BSE Announcement Dated on 03/10/2024) With reference to the above, please find enclosed herewith the Minutes of 30th Annual General Meeting of the Company held at 11:00 A.M on Monday, the 30th September, 2024 through Video Conferencing ('VC')/ Other Audio Video Visual Means (OVAM) to seek the approval of members of the Company on resolutions set out in the Notice convening meeting. Read less.. (As Per BSE Announcement Dated on 11.10.2024)

Lincoln Pharmaceuticals Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Lincoln Pharmaceuticals Ltd	₹771.50	₹1,545.29
Sun Pharmaceuticals Industries Ltd	₹1,761.80	₹4,22,714.84
Divis Laboratories Ltd	₹5,818.40	₹1,54,460.24
Cipla Ltd	₹1,427.30	₹1,15,270.75
Dr Reddys Laboratories Ltd	₹1,288.45	₹1,07,511.36
Torrent Pharmaceuticals Ltd	₹3,157.60	₹1,06,862.73

Lincoln Pharmaceuticals Ltd News

Lincoln Pharmaceuticals announces board meeting date

On 14 November 2024

07 Nov 2024, 02:08 pm

Lincoln Pharmaceuticals AGM scheduled

On 30 September 2024

03 Sep 2024, 05:11 pm

Lincoln Pharmaceuticals to conduct AGM

On 30 September 2024

03 Sep 2024, 11:39 am

Lincoln Pharmaceuticals to table results

On 8 August 2024

30 Jul 2024, 05:47 pm

Board of Lincoln Pharmaceuticals recommends Final Dividend

Of Rs.1.80 per share

16 May 2024, 12:16 pm

Lincoln Pharmaceuticals Ltd Stock Analysis

Annual revenue for Lincoln Pharmaceuticals Ltd increased by 15.42% to ₹614.97 crore in FY 2024 from ₹532.79 crore in FY 2023.
Annual Net Profit for Lincoln Pharmaceuticals Ltd increased by 27.99% to ₹93.30 crore in FY 2024 from ₹72.90 crore in FY 2023.
Promoter Shareholding in Lincoln Pharmaceuticals Ltd remains unchanged by 0.00% in the most recent quarter, from 49.78% in September 2024 to 49.78% in December 2024.
Lincoln Pharmaceuticals Ltd delivered a 1-year return of 16.34% compared to the Nifty 50, which provided a return of 8.41% as of the last trading session.
Lincoln Pharmaceuticals Ltd share price moved down by 2.47% from its previous close of INR ₹770.20. The latest Lincoln Pharmaceuticals Ltd share price is INR ₹751.15.
Lincoln Pharmaceuticals Ltd share price today has been at a low of 731.80 and a high of 774.45. Over the past 52 weeks, the Lincoln Pharmaceuticals Ltd share price has seen a low of 534.80 and a high of 979.50.